Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-crystalline Megestrol Acetate for Anorexia-Cachexia in Advanced Lung Cancer
NCT07092137Phase 2Not yet recruiting
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of megestrol in cancer anorexia-cachexia syndrome (CACS), sponsored by Guangzhou Institute of Respiratory Health. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on NCT07092137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07092137.